Nathan Caffo
Corporate Officer/Principal presso CANDEL THERAPEUTICS, INC.
Posizioni attive di Nathan Caffo
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANDEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2020 | - |
Storia della carriera di Nathan Caffo
Precedenti posizioni note di Nathan Caffo
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALX ONCOLOGY HOLDINGS INC. | Corporate Officer/Principal | 01/09/2018 | 01/09/2020 |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Chief Executive Officer | 01/04/2009 | 17/07/2018 |
President | 01/04/2009 | 01/08/2018 |
Formazione di Nathan Caffo
The Pennsylvania State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
President | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
CANDEL THERAPEUTICS, INC. | Health Technology |
ALX ONCOLOGY HOLDINGS INC. | Health Technology |
Aziende private | 1 |
---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Nathan Caffo
- Esperienza